anonymous
Guest
anonymous
Guest
Burst is where it's at peeps!!!!! Bone up and realize that fact please![]()
When is burst getting fda approval?
Burst is where it's at peeps!!!!! Bone up and realize that fact please![]()
When is burst getting fda approval?
The only FDA that the Burst will be receiving is F@#$ in Da Ass
But the data is so compelling!
Swink & Johnson are clowns. Just ask some of the Reps that have worked there and have since departed or are prepared to depart.
Johnson is more like a circus. Completely full of sh-- and as incompetent as there is
Johnson is more like a circus. Completely full of sh-- and as incompetent as there is
They're not so bad. They are both successful stim guru's with great relationships and really understand the business
May know biz but Johnson has no business trying to lead or manage anything. Rep at best. Used car salesman more appropriate
Swink & Johnson are clowns. Just ask some of the Reps that have worked there and have since departed or are prepared to depart.
Johnson is playing well over his pay grade. That's because he's Enxing's bi---.
Johnson is playing well over his pay grade. That's because he's Enxing's bi---.
Received a call from a recruiter about an opportunity at Nevro. Made some additional calls to gain more information. Sounds like there is significant turnover in the field and not good feedback on the management group either. Is the place that dysfunctional? Looking for some more info before moving forward with process. Recruiter talking it up pretty good but grass roots telling me otherwise. What's the deal? Why such conflicting reports?
Received a call from a recruiter about an opportunity at Nevro. Made some additional calls to gain more information. Sounds like there is significant turnover in the field and not good feedback on the management group either. Is the place that dysfunctional? Looking for some more info before moving forward with process. Recruiter talking it up pretty good but grass roots telling me otherwise. What's the deal? Why such conflicting reports?
Here is the litmus test for selling Nevro:
http://www.ncbi.nlm.nih.gov/m/pubmed/26218762/
If you can sell on this data, you'll do fine.
Awesome, I can hardly wait for the "litmus" material supporting coverage to use! Until then I'll just keep using MDT and SJM
The next earnings call will be in a couple of weeks and should be a good indicator of any coverage issues Nevro is having.